FBIO

Fortress Biotech Inc. Common Stock (FBIO)

Stock · NASDAQ · Health Care

$2.77as of 8/28/2026

Active signals

Support level
$2.75
Industry
Biotechnology: Pharmaceutical Preparations

About FBIO

Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne;…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
78

Fundamentals

1-day range
$2.75$2.81
Market cap
$92.02M
P/E (trailing)
0.75
P/E (forward)
-1.57
EPS (trailing)
$3.44
Dividend yield
Beta
1.20
Avg. volume
613.5K
52-week range
$2.18$4.53
Next earnings: August 13, 2025 · EPS estimate $-0.31confirmed

How Fortress Biotech Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$61.24MNet Income$6.82M (11%)SG&A$96.40M (157%)Cost of Revenue$20.92M (34%)FBIO

Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$17
+513.7%
Median
$11
+297.1%
Low
$5
+80.5%

Fortress Biotech Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • FBIO
    Fortress Biotech Inc. Common Stock
    $2.77
    ▼ 1.07%
    Market cap $92.02MP/E 0.75
    $2.18$4.53
  • VRCA
    Verrica Pharmaceuticals Inc. Common Stock
    $5.54
    ▲ 9.27%
    Market cap $92.08MP/E
    $3.28$9.82
  • NTHI
    NeOnc Technologies Holdings Inc. Common Stock
    $4.69
    ▲ 1.74%
    Market cap $90.77MP/E
    $3.01$12.99
  • ONCY
    Oncolytics Biotech Inc. Common Stock
    $0.8457
    ▼ 0.51%
    Market cap $95.55MP/E
    $1.39$1.44
  • ALDX
    Aldeyra Therapeutics Inc. Common Stock
    $1.49
    ▼ 3.57%
    Market cap $95.91MP/E
    $1.07$6.18
  • RANI
    Rani Therapeutics Holdings Inc. Class A Common Stock
    $0.845
    ▼ 1.05%
    Market cap $96.76MP/E
    $0.44$3.87
  • MAIA
    MAIA Biotechnology Inc. Common Stock
    $1.33
    ▼ 3.99%
    Market cap $86.34MP/E
    $0.87$3.19

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
1.35M
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
5.57M
Total value held
$13.84M
Institutional holders
49
Top holders this quarter
  • Unknown1.04M
  • Unknown966.0K
  • Unknown506.6K
  • Unknown305.5K
  • Unknown290.3K
  • Unknown254.1K
  • Unknown230.1K
  • Unknown209.4K
  • Unknown197.1K
  • Unknown196.8K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.